Multicentric, observational, prospective, non-interventional study with occasional biological sample collection (serum bank, urine bank and tumor bank)
This project is an exploratory study, based on the hypothesis of involvement of chemokines in hormonal escape of prostate cancers. The two main objectives are: * To describe the variations in expression of chemokines in serum and urine level in patients with prostate cancer * And to study the disease stage and intra-prostatic concentrations of chemokines based on serum and urine concentrations of chemokines before treatment initiation. These estimates can be used in future trials set up for the management of prostate cancer
Study Type
OBSERVATIONAL
Additional blood samples at baseline, 6, 12, 18 and 24 months.
Additional urine samples at baseline, 6, 12, 18 and 24 months.
Institut Bergonié
Bordeaux, France
Concentration of chemokines initially detectable in the blood or urine and evolution during follow-up: CXCL1, CXCL5, CXCL8, CXCL12, cytokine IL-6. Measurement was made by Luminex or elisa technical
Time frame: At baseline
Concentration of chemokines initially detectable in the blood or urine and evolution during follow-up: CXCL1, CXCL5, CXCL8, CXCL12, cytokine IL-6. Measurement was made by Luminex or elisa technical
Time frame: At 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.